Anzeige
Mehr »
Login
Montag, 28.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Warum diese Minenaktie Ihre beste Absicherung gegen wirtschaftliches Chaos sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
210 Leser
Artikel bewerten:
(1)

Exponential Science Launches to Advance the Convergence of Blockchain with AI, and Other Deep Tech

  • Exponential Science, a global non-profit foundation supported by leading technology companies like Hedera, drives innovation in emerging technologies to tackle complex challenges and deliver groundbreaking solutions.
  • With global operations, the Foundation fosters open collaboration and co-creation between academia, industry, government, the open-source community, and startups.
  • The launch details were announced on stage during the exclusive 10th annual P2P Financial Systems International Workshop, in Dubai.

DUBAI, UAE, Oct. 17, 2024 /PRNewswire/ -- Dr. Paolo Tasca, Founder and Chairman, and Nikhil Vadgama, Founder and Director, have launched Exponential Science, a non-profit foundation, created to build on their legacy of leadership in the blockchain space through the DLT Science Foundation.

Exponential Science was established to address the growing interdependencies among emerging digital technologies and deep tech. It will focus on the complementarity of blockchain with other cutting-edge technologies, including artificial intelligence, quantum computing, AR/VR and other deep tech.

Exponential Science leverages the expertise of Dr. Tasca and Nikhil Vadgama. Tasca is a renowned professor and economist with an extensive background in distributed systems and digital innovation. He has advised organizations such as the United Nations and several central banks on CBDC and Fintech. He co-founded the UCL Centre for Blockchain Technologies and also co-founded several top Web3 companies. Prof. Vadgama, has extensive experience in fintech, having launched innovative new businesses in multiple jurisdictions and worked with and advised a number of leading stakeholders, from industry participants to government officials. He is also an award-winning educator in the field of emerging technologies.

Both have witnessed the convergence of multiple emerging digital technologies, highlighting the need for interdisciplinary approaches to tackle complex societal and technological challenges. To address this, Exponential Science fosters open collaboration and co-creation among academia, industries, and government stakeholders. It also runs its cutting-edge science research department, comprised of renowned professors and visionary thinkers.

The team is made up of international academic and research experts from diverse fields and disciplines who are working on various initiatives, including the new MiCA Crypto Alliance, which helps blockchain and crypto businesses meet the EU's incoming regulatory requirements. Other key projects include work with the UK CBT, the national research hub that drives the UK agenda for blockchain, and DLT Earth, an initiative seeking to advance climate research, sustainable finance, and ESG reporting methodologies.

The foundation's upcoming plans include a range of initiatives aimed at expanding scientific impact and fostering collaboration across sectors. Research and spinoff initiatives will target specific challenges, enabling the exploration of niche areas of innovation and accelerating progress in critical fields. Complementing these efforts, a robust content and event strategy will be implemented, creating a dynamic platform for knowledge sharing and collaboration.

Exponential Science is backed by Hedera, a high-performance, secure, and sustainable public DLT network governed by the world's leading institutions. This backing enables Exponential Science to leverage extensive resources and expertise, further empowering its mission to drive interdisciplinary collaboration and deliver impactful solutions to societal challenges.

Dr Tasca said: "Our vision has always been about driving groundbreaking research and fostering collaboration across technological fields. With the launch of Exponential Science, we are expanding that vision to embrace a wider range of emerging technologies that are reshaping the digital landscape. We will navigate this fusion using a multi-disciplinary approach to explore how these technologies can work together to create solutions that address today's most pressing challenges."

Professor Vadgama commented: "Exponential Science represents our commitment to exploring and addressing the interconnectedness of today's technological landscape. By broadening our focus, we can leverage the combined power of multiple technologies to deliver transformative outcomes. Our objective is to empower open source communities and industries to thrive in this rapidly evolving landscape."

About Exponential Science

Exponential Science is a not-for-profit foundation driven to advance research, education, and innovation across emerging digital technologies and deep tech. With a mission to explore the convergence of blockchain, Artificial Intelligence (AI), the Internet of Things (IoT), and other transformative technologies, Exponential Science drives interdisciplinary collaboration to deliver impactful solutions to challenges faced by society. It brings together stakeholders from academic institutions, regulators, and diverse industries to drive innovative research and collaboration. Exponential Science is committed to fostering sustainable, transparent, and innovative developments that will shape a more advanced and interconnected future. For more information go to: www.exponentialscience.org.

Cision View original content:https://www.prnewswire.co.uk/news-releases/exponential-science-launches-to-advance-the-convergence-of-blockchain-with-ai-and-other-deep-tech-302279374.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.